These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33450873)

  • 1. Formation of Rutin-β-Cyclodextrin Inclusion Complexes by Supercritical Antisolvent Precipitation.
    Franco P; De Marco I
    Polymers (Basel); 2021 Jan; 13(2):. PubMed ID: 33450873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supercritical Antisolvent Precipitation of Corticosteroids/β-Cyclodextrin Inclusion Complexes.
    Mottola S; De Marco I
    Polymers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin/Carrier Coprecipitation by Supercritical Antisolvent Route.
    Mottola S; De Marco I
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes.
    Sri KV; Kondaiah A; Ratna JV; Annapurna A
    Drug Dev Ind Pharm; 2007 Mar; 33(3):245-53. PubMed ID: 17454057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
    Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
    Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of inclusion complex of apigenin-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement.
    Huang Y; Zu Y; Zhao X; Wu M; Feng Z; Deng Y; Zu C; Wang L
    Int J Pharm; 2016 Sep; 511(2):921-30. PubMed ID: 27515291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-state flurbiprofen and methyl-β-cyclodextrin inclusion complexes prepared using a single-step, organic solvent-free supercritical fluid process.
    Rudrangi SR; Kaialy W; Ghori MU; Trivedi V; Snowden MJ; Alexander BD
    Eur J Pharm Biopharm; 2016 Jul; 104():164-70. PubMed ID: 27163245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process.
    Zhao X; Zu Y; Jiang R; Wang Y; Li Y; Li Q; Zhao D; Zu B; Zhang B; Sun Z; Zhang X
    Int J Mol Sci; 2011; 12(4):2678-91. PubMed ID: 21731466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
    Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac.
    Dua K; Pabreja K; Ramana MV; Lather V
    J Pharm Bioallied Sci; 2011 Jul; 3(3):417-25. PubMed ID: 21966164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of host-guest complexes of β-cyclodextrin and perfluorooctanoic acid.
    Karoyo AH; Borisov AS; Wilson LD; Hazendonk P
    J Phys Chem B; 2011 Aug; 115(31):9511-27. PubMed ID: 21688796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
    Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
    Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
    Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
    Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
    Semalty M; Panchpuri M; Singh D; Semalty A
    Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
    Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
    Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques.
    Al-Marzouqi AH; Elwy HM; Shehadi I; Adem A
    J Pharm Biomed Anal; 2009 Feb; 49(2):227-33. PubMed ID: 19062214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.